BDRX - What's Going On With Biodexa Pharmaceuticals Stock (BDRX) Today? | Benzinga
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading lower by 6.8% to $4.76 Tuesday morning after the company announced an offering of 1,397,849 Class A Units at an assumed public offering price of $2.79 per Class A Unit in a preliminary prospectus.
The company on Monday announced it had acquired the rights to tolimidone, an experimental drug initially developed by ...
BDRX) Today?>Full story available on Benzinga.com